A new kind of pill sharply reduced cholesterol in people at high risk of heart attacks despite taking statins.
Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted ...
Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company ...
Australian researchers have developed a high‑performance coating made from peppermint essential oil that can be applied to ...
Experimental pill may offer new cholesterol-lowering option for millions - There are other pills that patients can add to ...
As a teenager, he began cleaning surgical equipment at Good Samaritan Hospital in Cincinnati. There, Fogarty found a mentor — ...
Every February, Children's of Alabama in Birmingham recognizes the patients and families at its Pediatric and Congenital ...
Heart patients in Rochester will soon benefit from a major investment in advanced cardiac care. Rochester General Hospital has reopened a fully renovated cardiac catheterization lab following a $1.5 ...
(GLOBE NEWSWIRE) -- (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted ...
Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination therapy for newly diagnosed multiple ...
The 1-channel ECG of the Apple Watch can detect atrial fibrillation that wasn't previously known. But it is also useful after ...
Boston Scientific Corporation (NYSE:BSX) Q4 2025 Earnings Call Transcript February 4, 2026 Boston Scientific Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results